Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh(California Institute for Regenerative Medicine), Louis M. Staudt(National Cancer Institute), Truc Tran(National Institutes of Health), Dennis D. Weisenburger(University of Nebraska Medical Center), Robert Tibshirani(Stanford University), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), John Powell(National Institutes of Health), Timothy C. Greiner(University of Nebraska Medical Center), Jennifer C. Boldrick, James E. Hudson(The University of Queensland), Izidore S. Lossos(University of Miami), Wyndham H. Wilson(National Institutes of Health), Michael R. Grever(The Ohio State University Wexner Medical Center), R. Eric Davis(National Institutes of Health), Gavin Sherlock(Stanford University), Jamés O. Armitage(University of Nebraska Medical Center), Patrick O. Brown(University of North Carolina at Chapel Hill), Michael B. Eisen(Howard Hughes Medical Institute), Hajeer Sabet(National Institutes of Health), Chi Ma(National Institutes of Health), Ronald Levy(Hôpital Necker-Enfants Malades), Xin Yu(National Institutes of Health), Liming Yang(Unknown), Lisheng Lü(Pediatrics and Genetics), David B. Lewis(Stanford Medicine), Wing C. Chan(Czech Academy of Sciences, Institute of Microbiology), Roger A. Warnke(Stanford University), David Botstein(Pediatrics and Genetics), John C. Byrd(University of Cincinnati), Gerald E. Marti, Troy Moore
Cited by 9,949
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Cell-Type Specific Features of Circular RNA Expression
|PLoS Genetics|2013|2.1k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k